Illustrative image – not actual.Glenmark Pharmaceuticals, which has acquired the manufacturing facility of GlaxoSmithkline at Ankleshwar in Gujarat, is planning expansion at the unit, with an investment of Rs.2-3 crore. The facility is expected to start production in January,2003.
Reportedly, the first phase of upgradation would be undertaken in 5-6 months duration.
The Ankleshwar facility, which has three manufacturing blocks spread over 50 acres, would be used to produce active pharmaceuticals ingredients targeted at the regulated market.
